A Goliath Grows: Pfizer Buys Wyeth For $68 Billion
This article was originally published in The Pink Sheet Daily
Executive Summary
Merger propels Pfizer ahead in biotechnology and paves the way for the drug giant to navigate the loss of Lipitor in 2011.